Although CD133 and ALDH can be used to identify and to enrich for ovarian cancer stem cells in fresh ovarian tumors, the expression of both markers is gradually reduced following prolonged in vitro cell passages, thus indicating that the in vitro cell culture conditions are not optimal for supporting stem cell properties, that probably need the presence of the tumor microenvironment. The gene discussed is PROM1; the disease is ovarian cancer.